Alpa Laboratories - Unaudited Financial Results for Sep 30, 2008
Alpa Laboratories Ltd has informed BSE about the unaudited financial results for the Quarter ended Sep 30, 2008.29-10-2008
29-10-2008
Alpa Laboratories - Change in Directorate
Alpa Laboratories Ltd has informed BSE that Mr. Sharad Chand Lunawat has been taken as an Independent Director on the board of the Company. Also, the resignation of Mr. Ashok Das Gupta who was an Independent Director has been accepted and processed.08-09-2008
Alpa Laboratories fixes Book Closure for AGM
Alpa Laboratories Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 22, 2008 to September 29, 2008 (both days inclusive) for the purpose of Annual General Meeting (AGM) of the Company to be held on September 29, 2008.28-08-2008
Alpa Laboratories - Changes in Directorate
Alpa Laboratories Ltd has informed BSE that the Mr. Kuldeep Singh Parwana has been taken as an Independent Director on the board of the Company. Also, the resignation of Mr. Vijay Padaki who was an Independent Director has been accepted and processed.29-07-2008
Alpa Laboratories enters into an agreement with Wockhardt
Alpa Laboratories Ltd has informed BSE that the Company has entered into an agreement with Wockhardt Ltd to manufacture products for further exports by Wockhardt.The Company is actively expanding its existing associations by joining hands with reputed parties all over the world.24-12-2007
Alpa Laboratories ties up with Vhermann Pharmaceutical Inc, Philippines for distribution of its products
Alpa Laboratories Ltd has informed BSE that the Company has appointed Vhermann Pharmaceutical Inc, Philippines as its agent for distribution of its products already registered in Philippines and to be registered in the future. Vhermann Pharma being a large importer of Drugs and Medicines in Philippines, it expects the volume of the business to reach between USD 4 million to USD 6 million per year....12-12-2007
Alpa Laboratories - Updates
Alpa Laboratories Ltd has informed BSE that the Company has appointed Tinez Pharmaceuticals Ltd, Nigeria as its agent for distribution of its products already registered in Nigeria and to be register in the future. Tinez Pharma being one of the biggest importers of Drugs and Medicines in Nigeria, it expects the volume of the business to reach between USD 6 million to USD 8 million within a year....12-09-2007
Alpa Laboratories - Updates
Alpa Laboratories Ltd has informed BSE that the Company has been allotted 13 locations for setting up Generic Drugs Retail Outlets by the Government of Bihar. The expected annual revenue from these outlets is about Rs 8 crores and the Company expects a net profit of about Rs 2 crores per year from these outlets. The tender was floated by the State Health Society, Bihar to operate an maintain Generic Drug Shop in each Medical College Hospital, in...22-08-2007
Alpa Laboratories clarifies on news item
With reference to the news item appearing in a leading web portal titled "Alpa Labs may enter tie-up / JV with Sudan's Marwaco, will mkt the product in Sudan via Marwaco, Rev seen at Rs 30-40 Cr", Alpa Laboratories Ltd has clarified to BSE that the Company has not issued any press releases or disseminated this news item in any other way.As for the tie-up or JV with Marwaco, the Company wish to clarify that it has been dealing with Marwaco...14-08-2007
Listing of equity shares of Alpa Laboratories Ltd
Trading Members of the Exchange are hereby informed that effective from August 06, 2007, the equity shares of Alpa Laboratories Ltd (Scrip Code: 532878) are listed and admitted to dealings on the Exchange in the list of 'B1' Group Securities. For further details please refer to the notice no 20070803-4 dated August 03, 2007.06-08-2007